Literature DB >> 6148641

Oral acyclovir for herpes zoster.

M W McKendrick, J I McGill, A M Bell, E Hickmott, C Burke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148641     DOI: 10.1016/s0140-6736(84)90678-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Herpes zoster ophthalmicus.

Authors:  R J Marsh
Journal:  J R Soc Med       Date:  1997-12       Impact factor: 5.344

2.  Clinical use of acyclovir.

Authors:  D J Jeffries
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19

3.  Pharmacokinetics and safety of multiple-dose valaciclovir in geriatric volunteers with and without concomitant diuretic therapy.

Authors:  L H Wang; M Schultz; S Weller; M L Smiley; M R Blum
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

4.  Treatment of peripheral neuropathies.

Authors:  M Hallett; D Tandon; A Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

Review 5.  Herpes zoster and postherpetic neuralgia. Optimal treatment.

Authors:  R W Johnson
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

6.  Severe herpes zoster infection in the United Kingdom: experience in a regional infectious disease unit.

Authors:  P Bannister; B Crosse
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

7.  Herpes zoster and its neurological complications.

Authors:  C M Chang; E Woo; Y L Yu; C Y Huang; D Chin
Journal:  Postgrad Med J       Date:  1987-02       Impact factor: 2.401

8.  Double-masked trial of topical acyclovir and steroids in the treatment of herpes zoster ocular inflammation.

Authors:  R J Marsh; M Cooper
Journal:  Br J Ophthalmol       Date:  1991-09       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.